source
- Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbumpAn unnamed pharma filed a citizen petition in April seeking reforms to the way the FDA publicly releases rejection letters, alleging that the policy “contravenes decades of agency practice.”BioSpace · 8d ago↗ source
- Chutes & Ladders—Biogen R&D vet gets in FormationAI-focused Formation Bio has found a new chief scientist with extensive experience in biotech, Big Pharma and academia. Michael Ehlers, M.D., Ph.D., is joining the 2025 Fierce 15 honoree as chief s…Fierce Biotech · 9d ago↗ source
- From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotechWhether it's looming tariff threats or the rise of China, you need a truly global view to navigate today's biopharma industry.